Roberta Smithey
Corporate Officer/Principal bij Apexian Pharmaceuticals, Inc.
Momenteel actieve connecties
| Naam | Geslacht | Leeftijd | Verwante bedrijven | Samenwerking |
|---|---|---|---|---|
| Tim Tichenor | M | - |
Apexian Pharmaceuticals, Inc.
 Apexian Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Apexian Pharmaceuticals, Inc. discovers, develops and commercializes novel pharmaceuticals products. It offers pharmaceutical products for the treatment of pancreatic cancer, blood cancer, brain tumors, ovarian cancer, age-related macular degeneration, and diabetic retinopathy. The company was founded by Mark R. Kelley in 2005 and is headquartered in Indianapolis, IN. | - |
| Mark R. Kelley | M | - |
Apexian Pharmaceuticals, Inc.
Apexian Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Apexian Pharmaceuticals, Inc. discovers, develops and commercializes novel pharmaceuticals products. It offers pharmaceutical products for the treatment of pancreatic cancer, blood cancer, brain tumors, ovarian cancer, age-related macular degeneration, and diabetic retinopathy. The company was founded by Mark R. Kelley in 2005 and is headquartered in Indianapolis, IN. | 19 jaar |
| David A. Broecker | M | 63 |
Apexian Pharmaceuticals, Inc.
Apexian Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Apexian Pharmaceuticals, Inc. discovers, develops and commercializes novel pharmaceuticals products. It offers pharmaceutical products for the treatment of pancreatic cancer, blood cancer, brain tumors, ovarian cancer, age-related macular degeneration, and diabetic retinopathy. The company was founded by Mark R. Kelley in 2005 and is headquartered in Indianapolis, IN. | 11 jaar |
| John Barnard | M | - |
Apexian Pharmaceuticals, Inc.
Apexian Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Apexian Pharmaceuticals, Inc. discovers, develops and commercializes novel pharmaceuticals products. It offers pharmaceutical products for the treatment of pancreatic cancer, blood cancer, brain tumors, ovarian cancer, age-related macular degeneration, and diabetic retinopathy. The company was founded by Mark R. Kelley in 2005 and is headquartered in Indianapolis, IN. | - |
| James H. Wikel | M | - |
Apexian Pharmaceuticals, Inc.
Apexian Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Apexian Pharmaceuticals, Inc. discovers, develops and commercializes novel pharmaceuticals products. It offers pharmaceutical products for the treatment of pancreatic cancer, blood cancer, brain tumors, ovarian cancer, age-related macular degeneration, and diabetic retinopathy. The company was founded by Mark R. Kelley in 2005 and is headquartered in Indianapolis, IN. | - |
| Homer Pearce | M | 71 |
Apexian Pharmaceuticals, Inc.
Apexian Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Apexian Pharmaceuticals, Inc. discovers, develops and commercializes novel pharmaceuticals products. It offers pharmaceutical products for the treatment of pancreatic cancer, blood cancer, brain tumors, ovarian cancer, age-related macular degeneration, and diabetic retinopathy. The company was founded by Mark R. Kelley in 2005 and is headquartered in Indianapolis, IN. | - |
| Martin F. Haslanger | M | - |
Apexian Pharmaceuticals, Inc.
Apexian Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Apexian Pharmaceuticals, Inc. discovers, develops and commercializes novel pharmaceuticals products. It offers pharmaceutical products for the treatment of pancreatic cancer, blood cancer, brain tumors, ovarian cancer, age-related macular degeneration, and diabetic retinopathy. The company was founded by Mark R. Kelley in 2005 and is headquartered in Indianapolis, IN. | - |
| Roger D. Miller | M | 74 |
Apexian Pharmaceuticals, Inc.
Apexian Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Apexian Pharmaceuticals, Inc. discovers, develops and commercializes novel pharmaceuticals products. It offers pharmaceutical products for the treatment of pancreatic cancer, blood cancer, brain tumors, ovarian cancer, age-related macular degeneration, and diabetic retinopathy. The company was founded by Mark R. Kelley in 2005 and is headquartered in Indianapolis, IN. | 10 jaar |
| William L. Current | M | - |
Apexian Pharmaceuticals, Inc.
Apexian Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Apexian Pharmaceuticals, Inc. discovers, develops and commercializes novel pharmaceuticals products. It offers pharmaceutical products for the treatment of pancreatic cancer, blood cancer, brain tumors, ovarian cancer, age-related macular degeneration, and diabetic retinopathy. The company was founded by Mark R. Kelley in 2005 and is headquartered in Indianapolis, IN. | 10 jaar |
Relatiegrafiek
Connectie in verschillende bedrijven
Statistieken
| Land | Connecties | % van het totaal |
|---|---|---|
| Verenigde Staten | 9 | 100.00% |
Ouderdom van de connecties
Actief
Verleden
Man
Vrouw
Besturend
Uitvoerend
Oorsprong van de connecties
- Beurs
- Insiders
- Roberta Smithey
- Persoonlijk netwerk
